(Q46707260)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334851%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

title

Phase II study of a combination of irinotecan and S-1 in patients with advanced gastric cancer (OGSG0002) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334851%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334851%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

author name string

Hiroyuki Narahara

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334851%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Ryu Ishihara

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334851%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Hiroya Takiuchi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334851%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Masahiro Goto

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334851%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Kazumasa Fujitani

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334851%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Motohiro Hirao

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334851%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Toshimasa Tsujinaka

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334851%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Motohiro Imano

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334851%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Hiroshi Furukawa

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334851%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Hideaki Tsukuma

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334851%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

Tetsuo Taguchi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334851%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334851%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334851%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

volume

73

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334851%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334851%20AND%20SRC:MED&resulttype=core&format=json

4 January 2020

page(s)

65-71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18334851%20AND%20SRC:MED&resulttype=core&format=json

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

4 January 2020

cites work

1 reference

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

21 January 2018

1 reference

Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.

21 January 2018

1 reference

Evolving chemotherapy for advanced gastric cancer

21 January 2018

1 reference

Randomised phase II study of docetaxel/cisplatin vs docetaxel/irinotecan in advanced non-small-cell lung cancer: a West Japan Thoracic Oncology Group Study (WJTOG9803).

21 January 2018

1 reference

Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer

21 January 2018

1 reference

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

21 January 2018

1 reference

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

21 January 2018

1 reference

Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer: a phase II trial

21 January 2018

1 reference

Phase I study of S-1 combined with irinotecan (CPT-11) in patients with advanced gastric cancer (OGSG 0002).

21 January 2018

1 reference

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy

21 January 2018

1 reference

Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer

21 January 2018

1 reference

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

21 January 2018

1 reference

Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma.

21 January 2018

1 reference

Phase I study of irinotecan and S-1 combination therapy in patients with metastatic gastric cancer

21 January 2018

1 reference

Phase I/II study of S-1 combined with irinotecan for metastatic advanced gastric cancer

21 January 2018

1 reference

Use of modeling to evaluate the cost-effectiveness of cancer screening programs

21 January 2018

1 reference

Combination of irinotecan (CPT11) and 5-fluorouracil with an analysis of cellular determinants of drug activity

21 January 2018

1 reference

Cellular interactions of 5-fluorouracil and the camptothecin analogue CPT-11 (irinotecan) in a human colorectal carcinoma cell line

21 January 2018

1 reference